192 related articles for article (PubMed ID: 18591627)
1. Oligoarray comparative genomic hybridization in polycythemia vera and essential thrombocythemia.
Borze I; Mustjoki S; Juvonen E; Knuutila S
Haematologica; 2008 Jul; 93(7):1098-100. PubMed ID: 18591627
[No Abstract] [Full Text] [Related]
2. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
Zhan H; Spivak JL
Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
[TBL] [Abstract][Full Text] [Related]
3. Fast and reliable mutation detection of the complete exon 11-15 JAK2 coding region using non-isotopic RNase cleavage assay (NIRCA).
Kambas K; Mitroulis I; Kourtzelis I; Chrysanthopoulou A; Speletas M; Ritis K
Eur J Haematol; 2009 Sep; 83(3):215-9. PubMed ID: 19500139
[TBL] [Abstract][Full Text] [Related]
4. Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?
Teofili L; Foà R; Giona F; Larocca LM
Haematologica; 2008 Feb; 93(2):169-72. PubMed ID: 18245648
[No Abstract] [Full Text] [Related]
5. Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow.
Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
Leukemia; 2008 Jan; 22(1):194-5. PubMed ID: 17625603
[No Abstract] [Full Text] [Related]
6. [JAK2 mutation and thrombosis - recommendations for screening].
Linnemann B; Lindhoff-Last E
Dtsch Med Wochenschr; 2011 Dec; 136(48):2454-7. PubMed ID: 22109574
[No Abstract] [Full Text] [Related]
7. Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.
Michiels JJ; Pich A; De Raeve H; Gadisseur A
Acta Haematol; 2015; 133(1):52-5. PubMed ID: 25116159
[No Abstract] [Full Text] [Related]
8. No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis.
Ditschkowski M; Elmaagacli AH; Trenschel R; Steckel NK; Koldehoff M; Beelen DW
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1350-1. PubMed ID: 17162218
[No Abstract] [Full Text] [Related]
9. JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
Sureau L; Buors C; Ianotto JC; Boyer F; Tanguy-Schmidt A; Roy L; Cayssials E; Cailly L; Chomel JC; Chauveau A; Orvain C; Mansier O; Ranta D; Robles M; Gyan E; Hérault O; Nimubona S; Marchand T; Lippert E; Riou J; Ugo V; Luque Paz D
Blood Cancer J; 2022 Apr; 12(4):56. PubMed ID: 35395836
[No Abstract] [Full Text] [Related]
10. Experience with oral interferon-alpha in patients with essential thrombocythemia and polycythemia vera.
Quintás-Cardama A; Verstovsek S
Am J Hematol; 2007 Sep; 82(9):859. PubMed ID: 17597478
[No Abstract] [Full Text] [Related]
11. Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysis.
Tefferi A; Sirhan S; Sun Y; Lasho T; Finke CM; Weisberger J; Bale S; Compton J; LeDuc CA; Pardanani A; Thorland EC; Shevchenko Y; Grodman M; Chung WK
Leuk Res; 2009 May; 33(5):662-4. PubMed ID: 18937974
[TBL] [Abstract][Full Text] [Related]
12. PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.
Passamonti F; Pietra D; Rumi E; Arcaini L; Della Porta MG; Malcovati L; Pascutto C; Lazzarino M; Cazzola M
Leukemia; 2005 May; 19(5):888-9. PubMed ID: 15744342
[No Abstract] [Full Text] [Related]
13. [Essential thrombocythemia--a comparative study on polycythemia vera].
Ohsaka A; Tsuboyama A; Kano Y; Furukawa Y; Takeda K; Akashi S; Komatsu N; Muroi K; Ohta M; Takagi S
Rinsho Ketsueki; 1986 Mar; 27(3):285-91. PubMed ID: 3735683
[No Abstract] [Full Text] [Related]
14. The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis.
Barbui T; Thiele J; Carobbio A; Vannucchi AM; Tefferi A
Leukemia; 2015 Apr; 29(4):992-3. PubMed ID: 25425199
[No Abstract] [Full Text] [Related]
15. Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis.
Wanquet A; Courtier F; Guille A; Carbuccia N; Garnier S; Adélaide J; Gelsi-Boyer V; Mozziconacci MJ; Rey J; Vey N; Birnbaum D; Murati A
Leuk Lymphoma; 2019 May; 60(5):1289-1293. PubMed ID: 30601073
[No Abstract] [Full Text] [Related]
16. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
Vannucchi AM; Masala G; Antonioli E; Chiara Susini M; Guglielmelli P; Pieri L; Maggi L; Caini S; Palli D; Bogani C; Ponziani V; Pancrazzi A; Annunziato F; Bosi A
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2068-73. PubMed ID: 19531676
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients.
Spanoudakis E; Bazdiara I; Kotsianidis I; Margaritis D; Goutzouvelidis A; Christoforidou A; Tsatalas C; Bourikas G
Ann Hematol; 2009 Jul; 88(7):629-32. PubMed ID: 19096846
[TBL] [Abstract][Full Text] [Related]
18. Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation.
Spanoudakis E; Margaritis D; Kotsianidis I; Georgiou G; Tripsianis G; Anastasiadis A; Karakolios A; Pantelidou D; Panayiotidis P; Bourikas G; Tsatalas C
Leuk Res; 2008 Oct; 32(10):1593-6. PubMed ID: 18321571
[TBL] [Abstract][Full Text] [Related]
19. ASXL1 mutations in primary and secondary myelofibrosis.
Ricci C; Spinelli O; Salmoiraghi S; Finazzi G; Carobbio A; Rambaldi A
Br J Haematol; 2012 Feb; 156(3):404-7. PubMed ID: 21923651
[No Abstract] [Full Text] [Related]
20. Comparative genomic hybridization in polycythemia vera and essential thrombocytosis patients.
Herishanu Y; Lishner M; Bomstein Y; Kitay-Cohen Y; Fejgin MD; Gaber E; Amiel A
Cancer Genet Cytogenet; 2001 Jul; 128(2):154-7. PubMed ID: 11463455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
